Want to join the conversation?
$PRGO said that in the Rx segment, the company expects a 2H16 YoverY pricing erosion forecast of approx. 9-10%. Consequently, the company expects Rx net sales for 2016 to be approx. $1Bil, with adjusted operating margin forecasted to be in the low 40% range for the year.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?